Share:
Share this content in WeChat
X
Clinical Article
Application of DCE-MRI combined with IVIM quantitative parameters in the treatment evaluation of brucellosis spondylitis
ZHAO Pengfei  HE Hongbing  WANG Haohua  LI Yupu  ZHANG Zhaojing  QIAO Pengfei 

Cite this article as: ZHAO P F, HE H B, WANG H H, et al. Application of DCE-MRI combined with IVIM quantitative parameters in the treatment evaluation of brucellosis spondylitis[J]. Chin J Magn Reson Imaging, 2023, 14(12): 72-77. DOI:10.12015/issn.1674-8034.2023.12.012.


[Abstract] Objective To evaluate the therapeutic effect of Brucella spondylitis in the acute phase, we used dynamic contrast-enhanced MRI (DCE-MRI) combined with intravoxel incoherent motion (IVIM) quantitative parameters to observe the changes of various quantitative parameters during the disease treatment process and to select the best evaluation quantitative parameters.Materials and Methods We prospectively enrolled 30 patients with acute phase of first confirmed Brucella spondylitis. What's more, all patients underwent routine MRI, DCE-MRI, and IVIM scans 3 months after initial diagnosis and treatment. Measurement of volume transport constant (Ktrans), extracellular volume fraction (Ve), rate constant (Kep), slow diffusion coefficient (D), fast diffusion coefficient (D*), and perfusion fraction (f) in the most significant area of the lesion (most significantly enhanced area) in a controlled study; We used SPSS 25.0 statistical software for data analysis, and all indicators showed a non-normal distribution, represented by the median ± interquartile interval (M±Q). Wilcoxon rank sum test was used for statistical analysis of various quantitative parameters.Results Ktrans values were (0.53±0.02), (0.22±0.01) min-1, Ve values were 0.45±0.01, 0.48±0.03, Kep values were (1.18±0.04), (0.46±0.04) min-1, D values were (0.53±0.01)×10-3, (0.91±0.01) ×10-3 mm2/s, D* values were (6.01±0.26)×10-3, (5.81±0.21)×10-3 mm2/s, and f values were 0.32±0.04, 0.29±0.03, respectively, after the first diagnosis and treatment of Brucella spondylitis; The differences in Ktrans, Kep, and D values within the group were statistically significant (Z were -4.784, -4.783, and -4.786, respectively, with P<0.01).Conclusions The first application of DCE-MRI combined with IVIM quantitative parameters to evaluate the treatment effect of Brucella spondylitis in the acute phase provides a more scientific and objective evaluation of the microenvironmental changes from a microscopic perspective, providing a new basis for guiding clinical medication.
[Keywords] Brucellosis spondylitis;acute phase;magnetic resonance imaging;dynamic contrast-enhanced;intravoxel incoherent motion;treatment evaluation

ZHAO Pengfei1   HE Hongbing2   WANG Haohua1   LI Yupu1   ZHANG Zhaojing1   QIAO Pengfei1*  

1 Imaging Diagnosis Department, Inner Mongolia Medical University Affiliated Hospital, Hohhot 010050, China

2 Traditional Chinese Medicine, Mongolian Medicine, Brucella Disease Department, Hohhot Second Hospital, Hohhot 010031, China

Corresponding author: QIAO P F, E-mail: qpfff@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Inner Mongolia Autonomous Region Natural Science Foundation Project (No. 2023QN08044); Inner Mongolia Autonomous Region Health Science and Technology Plan Project (No. 202202177); Inner Mongolia Medical University Youth Cultivation Project (No.YKD2021QN032).
Received  2023-09-06
Accepted  2023-12-07
DOI: 10.12015/issn.1674-8034.2023.12.012
Cite this article as: ZHAO P F, HE H B, WANG H H, et al. Application of DCE-MRI combined with IVIM quantitative parameters in the treatment evaluation of brucellosis spondylitis[J]. Chin J Magn Reson Imaging, 2023, 14(12): 72-77. DOI:10.12015/issn.1674-8034.2023.12.012.

[1]
GAO G X, LIAN X Y, LIU W B, et al. Analysis of clinical treatment of lumbar brucellosis[J]. J Dali Univ, 2022, 7(4): 60-62. DOI: 10.3969/j.issn.2096-2266.2022.04.012.
[2]
JIANG H, KAN B. Current status, progress and suggestions regarding prevention and control of brucellosis in China[J]. Chin J Epidemiol, 2020, 41(9): 1424-1427. DOI: 10.3760/cma.j.cn112338-20200408-00536.
[3]
DILIXIATI •ABULIZI, FAN J, MA L. Expert consensus on the diagnosis and treatment of Brucella spondylitis[J]. Chin J Antituberc, 2022, 44(6): 531-538. DOI: 10.19982/j.issn.1000-6621.20220138.
[4]
YANG H M, CHEN Q, LI Y, et al. Epidemic characteristics, high-risk areas and space-time clusters of human brucellosis-China, 2020-2021[J]. China CDC Wkly, 2023, 5(1): 17-22. DOI: 10.46234/ccdcw2023.004.
[5]
MA H R, XU H J, WANG X, et al. Molecular characterization and antimicrobial susceptibility of human Brucella in Northeast China[J/OL]. Front Microbiol, 2023, 14: 1137932 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/37125183/. DOI: 10.3389/fmicb.2023.1137932.
[6]
WARETH G, DADAR M, ALI H, et al. The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: current situation and therapeutic management[J/OL]. Transbound Emerg Dis, 2022, 69(5): e1253-e1268 [2023-04-14]. https://pubmed.ncbi.nlm.nih.gov/35244335/. DOI: 10.1111/tbed.14502.
[7]
AMJADI O, RAFIEI A, MARDANI M, et al. A review of the immunopathogenesis of brucellosis[J]. Infect Dis, 2019, 51(5): 321-333. DOI: 10.1080/23744235.2019.1568545.
[8]
LI X N, WANG Z L, HAI J, et al. Analysis on the curative effect of Mongolian medicine combined with TCM and Western medicine on brucellosis[J]. J Baotou Med Coll, 2023, 39(5): 34-37, 60. DOI: 10.16833/j.cnki.jbmc.2023.05.007.
[9]
LI F D, DU L P, ZHEN H, et al. Follow-up outcomes of asymptomatic brucellosis: a systematic review and meta-analysis[J/OL]. Emerg Microbes Infect, 2023, 12(1): 2185464 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/36849445/. DOI: 10.1080/22221751.2023.2185464.
[10]
HU J, ZHANG X Y, YANG H X, et al. Brucellosis screening and follow-up of seropositive asymptomatic subjects among household members of shepherds in China[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(6): 1325-1328. DOI: 10.1007/s10096-020-04115-z.
[11]
GUO H, LIU W Y, LI H J. Experts consensus on imaging diagnosis of Brucella spondylitis[J]. Chin J Med Imag Technol, 2023, 39(7): 961-965. DOI: 10.13929/j.issn.1003-3289.2023.07.001.
[12]
NIU H, GAO Y, QIAO P F, et al. Dynamic contrast-enhanced MRI in the early diagnosis of brucella spondylitis[J]. Chin J Radiol, 2017, 51(6): 437-440. DOI: 10.3760/cma.j.issn.1005-1201.2017.06.008.
[13]
ZHAO P F, GAO Y, QIAO P F, et al. The value of dynamic contrast-enhanced MRI in the differentiation of brucellosis spondylitis, tuberculous spondylitis and spinal metastatic tumors[J]. Chin J Radiol, 2017, 51(3): 197-201. DOI: 10.3760/cma.j.issn.1005?1201.2017.03.009.
[14]
WU X P, GAO Y, WU H, et al. IVIM in the differential diagnosis of brucellosis spondylitis, tuberculous spondylitis and spinal metastatic tumors[J]. J Clin Radiol, 2018, 37(5): 828-832. DOI: 10.13437/j.cnki.jcr.2018.05.029.
[15]
YANG H, JIANG L, LI J, et al. Quantitative DCE-MRI: an efficient diagnostic technique for evaluating early micro-environment permeability changes in ankylosing spondylitis[J/OL]. BMC Musculoskelet Disord, 2020, 21(1): 774 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/33234145/. DOI: 10.1186/s12891-020-03805-1.
[16]
FARNETI A, BOTTERO M, FAIELLA A, et al. The prognostic value of DCE-MRI findings before salvage radiotherapy after radical prostatectomy[J/OL]. Cancers, 2023, 15(4): 1246 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/36831588/. DOI: 10.3390/cancers15041246.
[17]
THAWANI R, GAO L N, MOHINANI A, et al. Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study[J/OL]. BMC Med Imaging, 2022, 22(1): 182 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/36266631/. DOI: 10.1186/s12880-022-00908-0.
[18]
MAO L Q, ZHU J G, LI H G, et al. A comparative study of IVIM-DWI combined with DCE-MRI quantitative parameters and MRE activity classiffcation in the assessment of Crohn's disease activity[J]. Chin J CT MRI, 2023, 21(3): 155-158. DOI: 10.3969/j.issn.1672-5131.2023.03.055.
[19]
KANG L Q, GUO S Y, ZHAO M, et al. Diagnostic value of the combination of IVIM-DWI and DCE-MRI in pelvic lymphatic metastasis of rectal cancer[J]. Chin J Magn Reson Imag, 2019, 10(8): 583-588. DOI: 10.12015/issn.1674-8034.2019.08.005.
[20]
JIAO H W, ZHOU Z X, LI B W, et al. The mechanism of facultative intracellular parasitism of Brucella[J/OL]. Int J Mol Sci, 2021, 22(7): 3673 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/33916050/. DOI: 10.3390/ijms22073673.
[21]
QIN J, LI J, YANG H, et al. Values of intravoxel incoherent motion diffusion weighted imaging and dynamic contrast-enhanced MRI in evaluating the activity of sacroiliitis in ankylosing spondylitis of rat model[J]. Magn Reson Imaging, 2020, 68: 30-35. DOI: 10.1016/j.mri.2020.01.007.
[22]
LIU L, ZHOU Z M, HUA S Y, et al. Detection of the disease activity with ankylosing spondylitis through intravoxel incoherent motion diffusion-weighted MR imaging of sacroiliac joint[J/OL]. Br J Radiol, 2022, 95(1133): 20211074 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/35195441/. DOI: 10.1259/bjr.20211074.
[23]
LALLEMAND F, LEROI N, BLACHER S, et al. Tumor microenvironment modifications recorded with IVIM perfusion analysis and DCE-MRI after neoadjuvant radiotherapy: a preclinical study[J/OL]. Front Oncol, 2021, 11: 784437 [2023-06-11]. https://pubmed.ncbi.nlm.nih.gov/34993143/. DOI: 10.3389/fonc.2021.784437.
[24]
ZHOU Z W, LENG X, ZENG D H, et al. Evaluation of quantitative parameters of IVIM-DWI and DCE-MRI on the microcirculation of femoral head necrosis and their correlation with ARCO staging[J]. J Clin Radiol, 2022, 41(2): 303-308. DOI: 10.13437/j.cnki.jcr.2022.02.004.
[25]
LIN M G, CHEN X Y, YU S, et al. Quantitative evaluation of sacroiliac arthritis activity in SpA based on DCE-MRI microvascular permeability parameters[J]. Chin J Magn Reson Imag, 2021, 12(4): 39-44. DOI: 10.12015/issn.1674-8034.2021.04.008.

PREV Evaluation of DWI on the early therapeutic efficacy of HIFU in adenomyosis
NEXT Quantitative evaluation of sacroiliac arthritis activity in ankylosing spondylitis based on magnetic resonance image compilation sequences
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn